Physician profile
Sandra Morales
NPI 1538128228
$1,186.41
in general payments reported to CMS, 2019-2025
17 companies · $259 in 2025
The $259 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $98.62 · 2022: $96.79 · 2023: $180 · 2024: $278 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $306.95 | 2019-2023 | |
| Abbott Laboratories | $146.10 | 2024 | Cardiomems |
| Sanofi Pasteur INC. | $134.44 | 2019-2025 | |
| Glaxosmithkline, LLC. | $112.59 | 2020-2025 | Bexsero, Penmenvy |
| Cranial Technologies, INC | $110.20 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $61.08 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $54.77 | 2025 | Daybue |
| Tris Pharma INC | $54.39 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $42.52 | 2024-2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $34.34 | 2025 | Jornay Pm |
| Corium, LLC | $31.61 | 2023 | Azstarys |
| Kaleo, INC. | $29.29 | 2019-2022 | |
| Alk-Abello, INC | $17.24 | 2025 | Neffy |
| Phadia US INC. | $13.07 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.86 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.64 | 2019 | |
| Merck Sharp & Dohme LLC | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.